|
US2014235571A1
|
|
Method for treatment of pulmonary fibrosis
|
|
AU2013329148A1
|
|
Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
|
|
AU2013315019A1
|
|
Method for enhancing specific immunotherapies in cancer treatment
|
|
CA2875979A1
|
|
Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase
|
|
CA2861492A1
|
|
Composition of novel carbohydrate drug for treatment of human diseases
|
|
CN103945695A
|
|
Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
|
